You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Deletion of the short arm of chromosome 17 (Del[17p])

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Acalabrutinib (Arm A)
  • Acalabrutinib (Arm B)
  • Bethesda, Maryland
    Research Site
Jan 3, 2023

Multiple Myeloma, Deletion 17P Syndrome Trial in Italy (Daratumumab, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Deletion 17P Syndrome
  • Ancona, Italy
  • +14 more
Mar 24, 2022

Healthcare Resources in Chronic Lymphocytic Leukemia Initiating

Completed
  • Chronic Lymphocytic Leukemia
    • Calgary, Alberta, Canada
    • +12 more
    Jul 7, 2022

    Chronic Lymphocytic Leukemia Trial in Worldwide (Venetoclax)

    Completed
    Has Results
    • Chronic Lymphocytic Leukemia
    • Louisville, Kentucky
    • +66 more
    Nov 9, 2022

    22q11 Deletion Syndrome, DiGeorge Syndrome, Trisomy 21 Trial in Worldwide

    Completed
    • 22q11 Deletion Syndrome
    • +10 more
      • San Francisco, California
      • +20 more
      Jan 27, 2021

      Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Obinutuzumab, Venetoclax, Fludarabine)

      Recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • Aurora, Colorado
      • +55 more
      Jan 30, 2023

      Chromosome 9 P Minus Syndrome

      Recruiting
      • Chromosome 9P Deletion Syndrome
      • +4 more
        • Saint Louis, Missouri
          Washington University School of Medicine
        Nov 30, 2021

        Chronic Lymphocytic Leukemia Trial in Germany (Obinutuzumab, Venetoclax, Acalabrutinib)

        Recruiting
        • Chronic Lymphocytic Leukemia
        • Bad Saarow, Germany
        • +29 more
        May 4, 2022

        Multiple Myeloma Trial in France (Isatuximab, ASCT)

        Recruiting
        • Multiple Myeloma
        • AMIENS Cedex 1, France
        • +67 more
        Mar 28, 2022

        Natural History Study of Smith-Magenis Syndrome

        Active, not recruiting
        • Smith-Magenis Syndrome (SMS)
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 4, 2023

          Leukemia, Lymphocytic, Chronic Trial in Germany (ibrutinib, obinutuzumab, venetoclax)

          Completed
          • Leukemia, Lymphocytic, Chronic
          • Dresden, Germany
          • +10 more
          Jan 13, 2023

          22q13 Deletion Syndrome, Phelan-McDermid Syndrome Trial in New York (Insulin-Like Growth Factor-1 (IGF-1), Normal saline)

          Completed
          Has Results
          • 22q13 Deletion Syndrome
          • Phelan-McDermid Syndrome
          • Insulin-Like Growth Factor-1 (IGF-1)
          • Normal saline
          • New York, New York
            Seaver Austin Center, Icahn School of Medicine at Mount Sinai
          Apr 18, 2022

          Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Venetoclax)

          Completed
          • Chronic Lymphocytic Leukemia (CLL)
          • La Plata, Buenos Aires, Argentina
          • +32 more
          Feb 10, 2022

          CLL, SLL Trial in Boston (Ofatumumab, High-Dose Methylprednisolone, Alemtuzumab)

          Terminated
          Has Results
          • CLL
          • SLL
          • Boston, Massachusetts
          • +1 more
          Jan 30, 2023

          Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)

          Not yet recruiting
          • Chronic Lymphocytic Leukemia
          • Small Lymphocytic Leukemia
          • (no location specified)
          Nov 30, 2022

          Chronic Myeloid Leukemia Trial in Italy (Venetoclax, Rituximab)

          Active, not recruiting
          • Chronic Myeloid Leukemia
          • Alessandria, Italy
          • +30 more
          Jan 3, 2022

          The Clinical Study of Sex Chromosome Variants

          Completed
          • Male Factor Infertility
          • Female Factor Infertility
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Apr 7, 2022

            Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

            Recruiting
            • Rare Disorders
            • +309 more
              • Sioux Falls, South Dakota
              • +1 more
              Jun 20, 2022

              Angelman Syndrome Trial (60 mg QD Alogabat, 40 mg QD Alogabat, 7 mg QD Alogabat)

              Not yet recruiting
              • Angelman Syndrome
              • 60 mg QD Alogabat
              • +4 more
              • (no location specified)
              Feb 1, 2023

              People Who Have Genetic Changes and Features of Autism: Simons

              Recruiting
              • 16P11.2 Deletion Syndrome
              • +184 more
                • New York, New York
                • +1 more
                Jan 6, 2023

                Chronic Lymphocytic Leukemia, 17p Deletion, Cancer of the Blood and Bone Marrow Trial in Worldwide (ABT-199 (Main Cohort),

                Completed
                Has Results
                • Chronic Lymphocytic Leukemia
                • +2 more
                • ABT-199 (Main Cohort)
                • ABT-199 (Safety Expansion Cohort)
                • Tucson, Arizona
                • +47 more
                Nov 19, 2021

                Newly Diagnosed Multiple Myeloma Trial in Austria, Germany (Elotuzumab, Carfilzomib, Lenalidomide)

                Active, not recruiting
                • Newly Diagnosed Multiple Myeloma
                • Krems, Lower Austria, Austria
                • +55 more
                Jan 4, 2022

                Partial PTEN Deletion in Breast Cancer

                Not yet recruiting
                • PTEN Gene Deletion
                  • (no location specified)
                  Oct 27, 2021

                  Myelodysplastic Syndrome Trial in Worldwide (Lenalidomide)

                  Completed
                  • Myelodysplastic Syndrome
                  • Centre City, New Jersey
                  • +148 more
                  Aug 18, 2022

                  Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III

                  Not yet recruiting
                  • Squamous Cell Carcinoma of Head and Neck
                  • +11 more
                  • KEYTRUDA®
                  • (no location specified)
                  Nov 17, 2023